trial · primary record
Hu3F8
Neuroblastoma
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 59 |
| Primary completion | 2025-09-29 |
| Primary endpoint | Relapse-free Survival (RFS) |
| Registry ID | NCT03033303 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:11.095Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03033303
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.